Article Text

Enhancing title and abstract screening for systematic reviews with GPT-3.5 turbo
  1. Omid Kohandel Gargari1,
  2. Mohammad Hossein Mahmoudi2,
  3. Mahsa Hajisafarali1,
  4. Reza Samiee3,4
  1. 1 Alborz Artificial Intelligence Association, Alborz University of Medical Sciences, Karaj, Alborz, Iran (the Islamic Republic of)
  2. 2 Industrial Engineering Department, Sharif University of Technology, Tehran, Iran (the Islamic Republic of)
  3. 3 NCWEB Association, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  4. 4 Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of)
  1. Correspondence to Dr Omid Kohandel Gargari, Alborz Artificial Intelligence Association, Alborz University of Medical Sciences, Karaj, Alborz, Iran (the Islamic Republic of); kohandelgargar{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

After conducting a database search, the subsequent phase in the execution of systematic reviews (SRs) involves title and abstract screening.1 This stage bears significant importance and necessitates the involvement of dedicated and experienced researchers who can exhibit precision and accuracy, particularly when the search yields a substantial number of studies. Besides the qualities of experience and dedication demonstrated by the screeners, several other factors influence the quality of the screening process, such as effective team management, the adoption of a double-screening approach and, notably, the implementation of a well-structured screening design. A screening tool comprises a set of questions that must be addressed by the screeners, and these questions should adhere to the following criteria: (1) they must be objective, (2) they should be single-barrelled and (3) they should encompass questions answerable with ‘yes’, ‘no’ or ‘unsure’ responses.2

The domain of large language and transformer models has showcased a promising trajectory of advancement, consistently improving day by day. These models are trained on a vast corpora of text and possess the capability to comprehend and generate human-like text.3 A prominent example within this realm is the Generative Pre-Trained Transformer (GPT) developed by OpenAI, with the latest iteration being GPT-4 at the time of composing this discourse. GPT-4 has exhibited commendable performance across a range of human-related tasks and has surpassed its predecessor, GPT-3.5, in evaluations conducted by the company.4

This single-case study was conceived to assess the performance of GPT 3.5 in the context of title and abstract screening for SRs. To execute this task, a recently published SR titled ‘Light Therapy in Insomnia Disorder: A Systematic Review and Meta-Analysis’ was selected, and the databases were queried using the keywords stipulated in the original paper.5 Two key rationales underpinned the selection of this review: first, it yielded a relatively moderate number of studies, and second, its eligibility criteria were somewhat subjective, and challenging to discern during the screening process, making it a suitable testbed to evaluate GPT-3.5’s capabilities. For instance, this study enrolled patients experiencing sleep difficulties but did not specify the particular types of sleep disorders although reviewers did not face much trouble but models had difficulties with studies that included patients with secondary sleeping troubles like patients with cancer. Furthermore, it was unclear which specific light therapy was chosen for inclusion.

The initial search yielded 330 citations, which were subsequently imported into EndNote X20. An RTF file containing titles and abstracts was generated, followed by its conversion into a more compatible TXT format, thus facilitating further data processing. This transformation laid the foundation for our experimental data set, comprising the research paper titles, abstracts and accompanying metadata. The screening team consisted of three researchers: (1) an expert with screening experience from over 20 SRs, (2) a senior researcher with screening experience from 10 SRs and (3) a junior researcher without any prior screening experience. All researchers possessed a strong command of the English language and a thorough understanding of SR principles.

The senior and junior researchers remained unaware of the study’s objectives. The three screeners were tasked with screening the titles and abstracts in accordance with the criteria outlined in the online supplemental table 1.

Supplemental material

To compare the performance of eligibility screening of the human screeners with the performance of GPT-3.5, a range of prompts were devised for GPT by two of the authors (OKG and MHM), these prompts were carefully chosen during several discussion sessions. A prompt is a specific input or instruction given to a language model, to generate a desired output or response. The integration of the OpenAI GPT 3.5 Turbo API played a pivotal role in advancing our research. This powerful tool enabled us to initiate requests to evaluate the pertinence of prompts to individual papers. The binary relevancy results of this interaction were recorded in a structured Pandas data frame that had been prepared in advance. The code for this process is available at the provided link: https://github.com/mamishere/Article-Relevancy-Extraction-GPT3.5-Turbo.

GPT evaluated the eligibility of studies based on the provided prompts, resulting in the creation of numpy arrays containing binary outcomes for each prompt response. These numpy arrays, along with the numpy arrays generated by the researchers, were employed to compute sensitivity, specificity, accuracy and the F1 score for both the researchers and the prompts. The labels used as the ‘gold standard’ were the studies included in the selected SR.5

Prompt 1, which replicated the criteria from the original paper, demonstrated 80% accuracy and 62% sensitivity. In contrast, Prompt 2 broadened the population by focusing on patients with ‘sleep troubles’ instead of providing a specific definition, leading to reduced accuracy, sensitivity, and specificity.

For subsequent prompts, GPT was assigned the role of an ‘Experienced Systematic Researcher’ (Prompt 3), which increased accuracy while decreasing sensitivity. Prompt 4 introduced an ‘inclusivity sentence’ to instruct the model to include studies it was uncertain about, prioritising inclusivity, leading to increased sensitivity and reduced specificity.

Prompt 5, which combined the original criteria with the inclusion of an ‘inclusivity sentence’, demonstrated the highest sensitivity, similar to the junior researcher and surpassing the senior researcher. Prompt 6, which omitted segmented criteria in favour of a more descriptive sentence, resulted in a significant reduction in sensitivity, suggesting that GPT responded better to segmented and classic criteria.

Prompt 7 assessed the impact of phrasing by modifying the language of the previous prompt and providing a more detailed description of the inclusivity phrase. This modification substantially increased the model’s sensitivity.

Lastly, Prompt 8 introduced a screening tool with four questions, requiring the model to include a study if the answer to all four questions was ‘Yes’ or ‘Unsure’. Surprisingly, the model performed poorly in this format, potentially due to the technical structure of GPT.

Our results indicate that more specific and detailed prompts elicit better responses, whereas broader and less specific prompts should be avoided, see online supplemental table 2 for performance metrics of 8 prompts three human screeners. We also recommend the incorporation of a sentence prioritising inclusivity to guide the model in including unclear studies.

Supplemental material

GPT is a potent tool, and we propose its usage in title and abstract screening for SRs, following the method we have delineated in this case report, alongside other researchers.6 However, it is imperative to recognise that GPT is not yet fully capable of independently completing this task and should be employed as an assistant to mitigate the risk of overlooking potential studies.

Notably, even the human researchers did not attain exemplary performance, attributable to the inherent challenges posed by the subjective criteria and the absence of clear, objective definitions. We advise researchers wanting to deploy GPT to manually screen a proportion of titles and abstracts, experiment with different prompts and consider the combination of findings, a method unexplored in our study. It is crucial to first establish a clear study objective before designing prompts.

The most formidable challenge encountered in this study pertained to defining the population for the model. For instance, the lack of clarity in the criteria for ‘sleep troubles’ resulted in substantial bias in the model’s performance and significant disparities among researchers. It needs to be acknowledged that the findings of this single-case study are not generalisable, and each study objective necessitates its distinct format. This study serves as an illustrative example and offers guidance for replication with more cases and further research on the topic.

The prompt texts are available in the online supplemental table 1.

Ethics statements

Patient consent for publication

Ethics approval

Not applicable.

References

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Twitter @Omidkohandelg

  • Contributors OKG: Designed the research, wrote the manuscript, data analysis, title and abstract screening. MHM: Wrote Python codes. MH and RS: Title and abstract screening.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.